Aaron Ondrey Rocket Pharmaceuticals, Inc. (RCKT) insider trading activity

RCKT Quotes by TradingView

Aaron Ondrey is Chief Financial Officer of ROCKET PHARMACEUTICALS, INC.. Currently has a direct ownership of 129,650 shares of RCKT, which is worth approximately $820,684. The most recent transaction as insider was on Apr 04, 2025, when has been sold 7,489 shares (Common Stock) at a price of $5.29 per share, resulting in proceeds of $39,616. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130K
177.14% 3M change
177.14% 12M change
Total Value Held $820,684

Aaron Ondrey Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 04 2025
SELL
Open market or private sale
$39,616 $5.29 p/Share
7,489 Reduced 5.46%
129,650 Common Stock
Feb 11 2025
BUY
Grant, award, or other acquisition
-
90,358 Added 39.72%
137,139 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
46,781 Added 50.0%
46,781 Common Stock

Also insider at

MRTX
Mirati Therapeutics, Inc. Healthcare
Chief Financial Officer
AO

Aaron Ondrey

Chief Financial Officer
San Diego, CA

Track Institutional and Insider Activities on RCKT

Follow ROCKET PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCKT shares.

Notify only if

Insider Trading

Get notified when an Rocket Pharmaceuticals, Inc. insider buys or sells RCKT shares.

Notify only if

News

Receive news related to ROCKET PHARMACEUTICALS, INC.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on RCKT